Andere Sprachen Eliem Therapeutics, Inc.

Aktien

A3CWUQ

US28658R1068

ELYM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.05.2024			% 5 Tage	% 1. Jan.
8,25 ^USD	+0,86 %		-2,48 %	+205,56 %

15.05.	Eliem Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
11.04.	Sektor-Update: Aktien des Gesundheitswesens am späten Nachmittag schwächer	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm	15.04.
Sector Update: Health Care Stocks Softer Late Afternoon	11.04.
Top Midday Gainers	11.04.
Sector Update: Health Care Stocks Decline Thursday Afternoon	11.04.
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge	11.04.
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders	11.04.
Top Premarket Gainers	11.04.
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement	11.04.
Eliem Therapeutics, Inc. and Tenet Medicines, Inc. Announces Management and Organization Changes	11.04.
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.	11.04.
Eliem Therapeutics, Inc. announced that it expects to receive $119.955003 million in funding from RA Capital Management, L.P., Deep Track Capital, LP	10.04.
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Harpoon Therapeutics Appoints Chief Legal Officer, Chief People Officer	26.12.
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
Eliem Therapeutics Drops Kv7 Program, Explores Strategic Alternatives	20.07.23
Eliem Therapeutics Plans to Explore Strategic Alternatives	20.07.23
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	20.07.23
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	20.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Eliem Therapeutics, Inc.

Aktien

A3CWUQ

US28658R1068

ELYM

Andere Sprachen

Filter